Rationale, design, and characteristics of a trial to evaluate the new phosphate iron-based binder sucroferric oxyhydroxide in dialysis patients with the goal of advancing the practice of E.B.M. (EPISODE)
Isaka, Yoshitaka, Fujii, Hideki, Tsujimoto, Yoshihiro, Teramukai, Satoshi, Hamano, TakayukiLanguage:
english
Journal:
Clinical and Experimental Nephrology
DOI:
10.1007/s10157-018-1547-5
Date:
March, 2018
File:
PDF, 948 KB
english, 2018